share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director DEPARLE NANCY ANN

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director DEPARLE NANCY ANN

西維斯健康 | 4：持股變動聲明-董事 DEPARLE NANCY ANN
美股sec公告 ·  05/18 05:38
牛牛AI助理已提取核心訊息
Nancy Ann Deparle, reported a completed acquisition of CVS Health Corp (CVS) common stock on May 16, 2024. The transaction involved the purchase of 2,314 shares at a price of $57.52 per share. Following this transaction, Deparle directly holds a total of 31,838 shares in the company. The acquisition, characterized as a grant, award, or other acquisition, reflects a positive investment move in the company by the reporting person.
Nancy Ann Deparle, reported a completed acquisition of CVS Health Corp (CVS) common stock on May 16, 2024. The transaction involved the purchase of 2,314 shares at a price of $57.52 per share. Following this transaction, Deparle directly holds a total of 31,838 shares in the company. The acquisition, characterized as a grant, award, or other acquisition, reflects a positive investment move in the company by the reporting person.
南希·安·德帕勒報告說，已於2024年5月16日完成對CVS Health Corp（CVS）普通股的收購。該交易涉及以每股57.52美元的價格購買2314股股票。在這筆交易之後，Deparle直接持有該公司總共31,838股股份。此次收購以補助金、獎勵或其他收購爲特徵，反映了申報人對公司的積極投資舉措。
南希·安·德帕勒報告說，已於2024年5月16日完成對CVS Health Corp（CVS）普通股的收購。該交易涉及以每股57.52美元的價格購買2314股股票。在這筆交易之後，Deparle直接持有該公司總共31,838股股份。此次收購以補助金、獎勵或其他收購爲特徵，反映了申報人對公司的積極投資舉措。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。